Sensus Healthcare, Inc. (SRTS) vs Tenax Therapeutics, Inc. (TENX)

A side-by-side comparison of Sensus Healthcare, Inc. and Tenax Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — SRTS vs TENX

growth of $100 · dividends reinvested · last 10y
SRTS -52.4% (-7.2%/yr)TENX -100.0% (-65.3%/yr)SRTS compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020182020202220242026$48$0
SRTS TENX

SRTS vs TENX: by the numbers

  • •TENX is the larger company ($51M vs $49M market cap).
  • •Both run net losses; TENX's is the smaller (0.00% vs -88.45% net margin).

Metrics side by side

Valuation

MetricSRTSTENX
P/S ratio2.79N/A
P/B ratio1.330.45

Profitability

MetricSRTSTENX
Gross margin36.39%0.00%
Operating margin-37.50%0.00%
Net margin-88.45%0.00%
ROE-42.01%-57.10%
ROIC-35.63%-60.40%

Growth (annualized)

MetricSRTSTENX
Revenue CAGR (5Y)2.86%N/A
Total return CAGR (5Y)-4.37%-76.80%

Frequently asked

How have SRTS and TENX total returns compared?
Over the past 10 years, SRTS delivered -7.40% and TENX delivered -64.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.